Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes

OBJECTIVE: To further evaluate the safety and efficacy of the Control-IQ closed-loop control (CLC) system in children with type 1 diabetes. RESEARCH DESIGN AND METHODS: After a 16-week randomized clinical trial (RCT) comparing CLC with sensor-augmented pump (SAP) therapy in 101 children 6–13 years o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Diabetes Care
Autores principales: Kanapka, Lauren G., Wadwa, R. Paul, Breton, Marc D., Ruedy, Katrina J., Ekhlaspour, Laya, Forlenza, Gregory P., Cengiz, Eda, Schoelwer, Melissa J., Jost, Emily, Carria, Lori, Emory, Emma, Hsu, Liana J., Weinzimer, Stuart A., DeBoer, Mark D., Buckingham, Bruce A., Oliveri, Mary, Kollman, Craig, Dokken, Betsy B., Cherñavvsky, Daniel, Beck, Roy W.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Diabetes Association 2021
Materias:
Emerging Technologies: Data Systems and Devices
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7818334/
https://ncbi.nlm.nih.gov/pubmed/33355258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc20-1729
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares